¼¼°èÀÇ °æ±¸ °íÇüÁ¦(OSD) ¼öŹÁ¦Á¶ ½ÃÀå(2024-2028³â)
Global Oral Solid Dosage (OSD) Contract Manufacturing Market 2024-2028
»óǰÄÚµå : 1557563
¸®¼­Ä¡»ç : TechNavio
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 169 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,500 £Ü 3,617,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,000 £Ü 5,787,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

°æ±¸ °íÇüÁ¦(OSD) ¼öŹÁ¦Á¶ ½ÃÀåÀº 2023-20281³â¿¡ 142¾ï ´Þ·¯, ¿¹Ãø ±â°£ Áß CAGRÀº 6.84%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

°æ±¸ °íÇüÁ¦(OSD) ¼öŹÁ¦Á¶ ½ÃÀåÀÇ ÀüüÀûÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð¡¤¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ ´Ù·é º¥´õ ºÐ¼® µîÀ» °ÔÀçÇϰí ÀÖ½À´Ï´Ù.

ÇöÀç ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ°ú ÃËÁø¿äÀÎ, ½ÃÀå ȯ°æ Àüü¿¡ °üÇÑ ÃֽŠºÐ¼®À» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ƯÇã ¸¸·á¿Í Á¦³×¸¯ ÀǾàǰÀÇ ¼ö¿ä Áõ°¡, ÇÙ½É ¿ª·®¿¡ ´ëÇÑ ÁÖ·Â ¿ä±¸ÀÇ Áõ°¡, ½ÅÈï ½ÃÀå¿¡¼­ ºñ¿ë È¿À²ÀÌ ³ôÀº ¸®¼Ò½ºÀÇ ÀÌ¿ë °¡´É¼º µîÀÌ ½ÃÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
±âÁسâ 2024
Á¾·á³â 2028
¿¹Ãø ±â°£ 2024-2028
¼ºÀå ¸ð¸àÅÒ °¡¼Ó
Àü³â´ëºñ 2024³â 6.35%
CAGR 6.84%
ÁõºÐ¾× 142¾ï ´Þ·¯

º» Á¶»ç¿¡¼­´Â ÇâÈÄ ¼ö³â°£ °æ±¸ °íÇüÁ¦(OSD) ¼öŹÁ¦Á¶ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÇ Çϳª·Î ¹Ì±¹ FDA Àΰ¡ Á¦Á¶ ½Ã¼³ÀÇ Áõ°¡¸¦ µé°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ OSD¸¦ Á¦Á¶ÇÏ´Â CMOS¿¡ ÀÇÇÑ ¾Ö³Î¸®Æ½½ºÀÇ ÀÌ¿ëÀÌ È®´ëÇϸç, ½ÃÀå ÅëÇÕÀÌ ÁøÇàµÇ´Â °ÍÀ¸·Î ÀÌ ½ÃÀåÀº Å« ¼ö¿ä°¡ Àü¸ÁµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ½ÃÀå ±¸µµ

Á¦3Àå ½ÃÀå ±Ô¸ðÀÇ Æò°¡

Á¦4Àå ½ÃÀå ±Ô¸ð ½ÇÀû

Á¦5Àå Five Forces ºÐ¼®

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­ : ÃÖÁ¾»ç¿ëÀÚº°

Á¦7Àå ½ÃÀå ¼¼ºÐÈ­ : Á¦Ç°º°

Á¦8Àå °í°´ »óȲ

Á¦9Àå Áö¿ªº° »óȲ

Á¦10Àå ÃËÁø¿äÀΡ¤°úÁ¦¡¤±âȸ¡¤¾ïÁ¦¿äÀÎ

Á¦11Àå °æÀï ±¸µµ

Á¦12Àå °æÀï ºÐ¼®

Á¦13Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The oral solid dosage (OSD) contract manufacturing market is forecasted to grow by USD 14.2 bn during 2023-2028, accelerating at a CAGR of 6.84% during the forecast period. The report on the oral solid dosage (OSD) contract manufacturing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by patent expiry and increasing demand for generic drugs, growing need to focus on core competencies, and availability of cost-efficient resources in emerging markets.

Technavio's oral solid dosage (OSD) contract manufacturing market is segmented as below:

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20246.35%
CAGR6.84%
Incremental Value$14.2 bn

By End-user

By Product

By Geographical Landscape

This study identifies the increasing number of US FDA-approved manufacturing facilities as one of the prime reasons driving the oral solid dosage (OSD) contract manufacturing market growth during the next few years. Also, growing use of analytics by cmos that manufacture OSD and increasing market consolidation will lead to sizable demand in the market.

The report on the oral solid dosage (OSD) contract manufacturing market covers the following areas:

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading oral solid dosage (OSD) contract manufacturing market vendors that include AbbVie Inc., Acino International AG, Aenova Holding GmbH, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim International GmbH, Catalent Inc., Corden Pharma International GmbH, Inglasia Pharma Solutions, Jubilant Pharmova Ltd., Koninklijke DSM NV, Lonza Group Ltd., Merck KGaA, NextPharma GmbH, Perkin Elmer Inc., Piramal Enterprises Ltd., Pyramid Laboratories Inc., Recipharm AB, Siegfried Holding AG, Thermo Fisher Scientific Inc., and Viatris Inc.. Also, the oral solid dosage (OSD) contract manufacturing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by End-user

7 Market Segmentation by Product

8 Customer Landscape

9 Geographic Landscape

10 Drivers, Challenges, and Opportunity/Restraints

11 Competitive Landscape

12 Competitive Analysis

13 Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â